General Information

Abstract submission is closed!


1. Brain Metastasis
2. Glioma
3. Lymphoma
4. Meningioma
5. Other

Once you have logged into the submission portal with your account, click on the “+New” button to start with your abstract submission.

Read through the affirmations carefully and confirm them.


  • In the title, please use capital letters ONLY where necessary (e.g. „Detection of two novel large mutations in SLC7A9 by semi-quantitative fluorescent multiplex PCR“).
  • Please DO NOT format the title in bold, underline, or enter line breaks. Use italics only where required by nomenclature.
  • The title is limited to 300 characters!


Please allocate your submission to a suitable topic from the list provided. Select only ONE topic that best relates to the main subject of your abstract.

  1. Brain Metastasis
  2. Glioma
  3. Lymphoma
  4. Meningioma
  5. Other


  • Please enter up to 3 keywords describing your work (required).


  • No more than 25 authors can be listed.
  • A maximum of 2 affiliations per author is allowed.
  • The order of the authors as well as the name of the presenting author (marked in green) can be edited during the submission process.
  • DISCLOSURE INFORMATION: In order to help readers form their own judgments of potential bias in published abstracts, submitters are asked to declare any competing financial interests of all authors. Contributions of up to EUR 10.000,- (or equivalent value in kind) per year per entity are considered „Modest“. Contributions above EUR 10.000,- per year are considered „Significant“.


The abstract body should be structured as follows:

–  Background
–  Material and Methods
–  Results
–  Conclusion

  • The text cannot exceed 300 words, excluding title and authors. Minimum 100 words.
  • The abstract must be submitted in good English.
  • Tables, graphics or illustrations are allowed.
  • No literature must be cited.
  • The text may be typed in or copy/pasted from an existing document.
  • Special characters are widely supported.


  • During submission, authors can select whether they prefer oral or poster presentation.
  • Please indicate your preference, especially in case you do not want your abstract to be selected for an oral presentation.


Please indicate if you want to apply for a Travel Scholarship by filling in the additional information. Only applicable for abstract submissions within the regular submission (deadline January 25, 2023).


  • The summary page will display all information related to your abstract.
  • You may print the summary page for your records (or save it as a pdf). The system also has an e-mail confirmation feature. Simply click the appropriate link on the summary page and fill in your email address(es) in the appropriate box.

If you choose to delete the submission, this can be made here. Please note that you will be able to retrieve deleted submissions.


  • Titles of submitted abstracts are displayed on your submission site, together with the information on whether the submission is complete or incomplete. To edit one of your abstracts, simply click on the title.
  • Submitted abstracts can be corrected / withdrawn via the online submission portal until the submission deadline of January 25, 2023..
  • Corrections or withdrawals after the deadline have to be requested in an email to
  • No corrections / withdrawals are possible after January 25, 2023.


  • For optimum results when using the online submission system, it is recommended to use one of the following browsers: Google Chrome, Mozilla FireFox or Safari.
  • Please note that in rare cases you may encounter an issue copy/pasting from Word on Mac, triggering an error message that your title cannot exceed 1,000 characters. In this case please reload the page and either type or copy/paste the title from a plain text application.
  • JavaScripts and cookies need to be enabled in your browser. Instructions to enable cookies are given on the login page.


Note: If you created an abstract submission account from 2021, please use this account.

  • The creation of a user account is required for the submission of an abstract. The account only needs to be created once (also if you choose to submit more than one abstract) and can be re-used for future NMN abstract submissions.
  • By using the username and password you created you will be able to return and edit, delete or withdraw your abstract at a later stage.
  • Personal information can be edited if necessary by clicking the „Profile“ icon (e.g. in case of an address change). Attention: All correspondence regarding the acceptance of your abstract will be emailed to the address given by you in the „author section“. Please provide a working email address.

First time users:

  1. When entering the online submission portal, click on „Create new account“. Fill in all required fields and save your personal information by clicking “Save & Continue” in the online form.
  2. Please remember to create a password not being used for other logins (i.e. bank accounts, market places etc.)
  3. Once you have logged into the submission portal, you will be directed to the abstract submission site. Click on the “+New” button to start with your abstract submission. If you cannot see this button, please make sure you are located in the tab labelled “submissions”.
  4. When clicking the “+New” button a new tab will open in your browser. Follow step by step the instructions for submission.
  5. At the end of the process, you will see a summary of your submission (“Review my work“). After submitting your abstract it should show as complete on your submission site.

Returning users submitting a new abstract:

  1. Login with the username and password you created.
  2. Click on the “+New” button to start a new submission.
  3. Carefully follow the step-by-step instructions.

Returning users continuing an aborted submission or editing an abstract already submitted:

  1. Login with the username and password you created.
  2. Locate the abstract and click on the displayed abstract title to make changes or complete the abstract.
  3. Continue your submission or click on the menu item you wish to change.
  4. Changes can be made until the submission deadline.

Detailed Information will follow soon.

With the submission of an abstract to the NMN Symposium: Precision Medicine meeting, the presenting authors agrees to the following (please read carefully):

  • confirms that all authors are aware of and agree to the content of the abstract and support the data presented and that no other regular abstract of the same content has been submitted via this abstract submission process.
  • accepts to be the contact person for all correspondence about the abstract and to inform co-authors and especially the presenting author about its status.
  • acknowledges that the presenting author of this abstract must register and pay the registration fee by March 13, 2024 otherwise this abstract will be rejected.
    ATTENTION: The regular registration payment period of 2 weeks does not apply in this case. This deadline also applies to presenting authors with a free registration.
  • states that for studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority, and properly informed consent given where appropriate.
  • accepts responsibility for the accuracy of the submitted abstract.
  • acknowledges that once the abstract is submitted, changes, corrections or rewording are only possible until the deadline of abstract submission (January 25, 2024).
  • agrees that the abstract submission is not possible without collecting, saving and processing my personal data (required fields with *). This is done in accordance with the most recent legislation on data protection (EU-GDPR 2018) and solely for the purpose of organising and realising the event. All abstracts including the author block will be published on the NMN Symposium website and online programme.
  • understands that the abstract submission system as well as the publication process is operated by USA based companies (CTI).
  • confirms that no person employed by a company as defined by the CMSS Code for Interactions with Companies is the first or presenting author on clinical abstracts or on abstracts on translational research from clinical trials.
  • acknowledges that employees of pharmaceutical and diagnostic companies can submit and present data generated in in-vitro and pre-clinical basic research, but not of translational research from clinical trials. The meeting presentation, whether oral or poster, must clearly describe all financial disclosures.
  • acknowledges that careful typing and proof-reading are essential as the abstract will appear, if accepted, as submitted.
  • acknowledges that no withdrawals are possible after March 13, 2024.

At least the presenting author of an abstract is obliged to register and pay the congress registration fee within 2 weeks (but not later than March 13, 2023) after notification on acceptance. In the event of non-fulfillment, the abstract will be withdrawn by the organisers.